Numerous studies have reported that high MCL-1 expression is linked to the occurrence, progression, metastasis, and poor prognosis of various tumors, including human breast, renal, hepatocellular, gastric, pulmonary, ovarian cancers, and lymphoma [2, 6–12]. Here, MCL1 is linked to ovarian carcinoma.